Repligen Corporation · NASDAQ:RGEN
Loeillot Olivier sold 12,946 Repligen Corporation shares (Form 4)
Traded Sep 24, 2026 · Filed Sep 25, 2026
On Sep 24, 2026, Loeillot Olivier (Director, Chief Executive Officer) sold 12,946 Repligen Corporation shares at US$190.00 for US$2.46M under a trading plan, leaving 48,369 shares. Filed Sep 25, 2026 (Form 4).
- Sold
- 12,946 shares
- Price
- US$190.00
- Value
- US$2.46M
- Holding after
- 48,369 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | Option exercise | 8,404 | US$154.96 | 56,773 | Direct |
| Sep 24, 2026 | Common Stock | Sale | 8,404 | US$190.00 | 48,369 | Direct |
| Sep 24, 2026 | Common Stock | Option exercise | 4,542 | US$155.38 | 52,911 | Direct |
| Sep 24, 2026 | Common Stock | Sale | 4,542 | US$190.00 | 48,369 | Direct |
Source
Related
- Repligen Corporation
- Loeillot Olivier
- Repligen Corporation shareholders
- Form 4 · Loeillot Olivier · Oct 6, 2026
- Form 4 · Loeillot Olivier · Oct 5, 2026
- Form 4 · Loeillot Olivier · Sep 22, 2026
- Form 4 · Loeillot Olivier · Sep 8, 2026
- Form 4 · Loeillot Olivier · Aug 21, 2026
- Form 4 · Douglass Brian Robb · Oct 8, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Garland Jason K · Sep 28, 2026
- Form 4 · Hughes Violetta · Sep 2, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026